Aurora Cannabis (TSE:ACB) Trading Up 41.3% – Here’s What Happened

Shares of Aurora Cannabis Inc. (TSE:ACB) traded up 41.3% during trading on Wednesday . The stock traded as high as C$7.57 and last traded at C$7.46. 934,168 shares traded hands during mid-day trading, an increase of 184% from the average session volume of 329,183 shares. The stock had previously closed at C$5.28.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on ACB shares. TD Securities raised shares of Aurora Cannabis to a “strong-buy” rating in a report on Thursday, December 12th. ATB Capital reduced their target price on shares of Aurora Cannabis from C$11.00 to C$8.50 in a report on Tuesday, December 17th. Three equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of C$5.85.

Aurora Cannabis Stock Performance

The company has a debt-to-equity ratio of 16.95, a quick ratio of 2.48 and a current ratio of 3.76. The company has a market cap of C$412.14 million, a price-to-earnings ratio of -11.97 and a beta of 2.71. The company has a fifty day moving average of C$6.00 and a two-hundred day moving average of C$7.16.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Wednesday, November 6th. The company reported C$0.05 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of C($0.30) by C$0.35. Aurora Cannabis had a negative return on equity of 6.13% and a negative net margin of 11.53%. During the same period in the prior year, the firm earned ($0.70) EPS. Equities research analysts anticipate that Aurora Cannabis Inc. will post -0.22 EPS for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.